Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs

Radiation Research

Volumn 168, Issue 1, 2007, Pages 106-114

  Kataoka, Yasushi ^a   Murley, Jeffrey S ^a   Baker, Kenneth L ^a   Grdina, David J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISULFIDE; HISTONE H2AX; THIOL DERIVATIVE; AMIFOSTINE; DRUG DERIVATIVE; H2AFX PROTEIN, HUMAN; HISTONE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE; CELL DEATH; CELL POPULATION; CELL PROTECTION; CELL SURVIVAL; COLONY FORMING UNIT; DNA CONTENT; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; IONIZING RADIATION; PHOSPHORYLATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; METABOLISM;

AMIFOSTINE; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HISTONES; HUMANS; PHOSPHORYLATION; RADIATION, IONIZING; SULFHYDRYL COMPOUNDS;

EID: 34548587650     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR0975.1     Document Type: Article

References (46)

1. A. Takahashi and T. Ohnishi, Does γH2AX foci formation depend on the presence of DNA double strand breaks? Cancer Lett. 229, 171-179 (2005).
2. E. P. Rogakou, D. R. Pilch, A. H. Orr, V. S. Ivanova and W. M. Bonner, DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273, 5858-5868 (1998).
3. T. Stiff, M. O'Driscoll, N. Rief, K. Iwabuchi, M. Lobrich and P. A. Jeggo, ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 64, 2390-2396 (2004).
4. T. T. Pauli, E. P. Rogakou, V. Yamazaki, C. U. Kirchgessner, M. Gellert and W. M. Bonner, A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10, 886-895 (2000).
5. E. P. Rogakou, C. Boon, C. Redon and W. M. Bonner, Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146, 905-916 (1999).
6. R. Shroff, A. Arbel-Eden, D. Pilch, G. Ira, W. M. Bonner, J. H. Petrini, J. E. Haber and M. Lichten, Distribution and dynamics of chromatin modification induced by a defined DNA double-strand break. Curr. Biol. 14, 1703-1711 (2004).
7. K. Rothkamm and M. Lobrich, Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc. Natl. Acad. Sci. USA 100, 5057-5062 (2003).
8. O. A. Sedelnikova, I. Horikawa, D. B. Zimonjic, N. C. Popescu, W. M. Bonner and J. C. Barrett, Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat. Cell Biol. 6, 168-170 (2004).
9. 125IdU-induced DNA double-strand breaks with γ-H2AX antibody. Radiat Res. 158, 486-492 (2002).
10. D. J. Grdina, J. S. Murley and Y. Kataoka, Radioprotectants: Current status and new directions. Oncology 63 (Suppl. 2), 2-10 (2002).
11. J. D. Chapman, D. L. Dugle, A. P. Reuvers, C. J. Gillespie and J. Borsa, Chemical radiosensitization studies with mammalian cells grown in vitro. In Radiation Research (O. F. Nygaard, H. I. Adler and W. K. Sinclair, Eds.), pp. 752-760. Academic Press, New York, 1975.
12. D. J. Grdina and C. P. Sigdestad, Radiation protectors: The unexpected benefits. Drug Metabol. Rev. 20, 13-42 (1989).
13. D. J. Grdina, Y. Kataoka and J. S. Murley, Amifostine: Mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol. Drug Interact. 16, 237-280 (2000).
14. C. P. Sigdestad, S. H. Treacy, L. A. Knapp and D. J. Grdina, The effect of 2-[(aminopropyl)amino]ethanethiol (WR1065) on radiation induced DNA double strand damage and repair in V79 cells. Br. J. Cancer 55, 477-482 (1987).
15. D. Murray, A. Prager and L. Milas, Radioprotection of cultured mammalian cells by the aminothiols WR1065 and WR255591: Correlation between protection against DNA double-strand breaks and cell killing after γ radiation. Radiat Res. 120, 154-163 (1989).
16. Y. Kataoka, V. P. Bindokas, R. C. Duggan, J. S. Murley and D. J. Grdina, Flow cytometric analysis of phosphorylated histone H2AX following exposure to ionizing radiation in human microvascular endothelial cells. J. Radial Res. 47, 245-257 (2006).
17. J. S. Murley, Y. Kataoka, C. J. Weydert, L. W. Oberley and D. J. Grdina, Delayed radioprotection by nuclear transcription factor κB-mediated induction of manganese superoxide dismutase in human microvascular endothelial cells after exposure to the free radical scavenger WR1065. Free Radic. Biol. Med. 40, 1004-1016 (2006).
18. P. L. Olive, Detection of DNA damage in individual cells by analysis of histone H2AX phosphorylation. Methods Cell Biol. 75, 355-373 (2004).
19. 1-phase cells. Radiat Res. 159, 759-767 (2003).
20. N. Shigematsu, J. L. Schwartz and D. J. Grdina, Protection against radiation-induced mutagenesis at the hprt locus by spermine and N,N″-(dithiodi-2,1-ethanediyl)bis-1,3-propanediamine (WR-33278). Mutagenesis 9, 355-360 (1994).
21. L. Giambarresi and A. J. Jacobs, Radioprotectants. In Military Radiobiology (J. J. Conklin and R. I. Walker, Eds.), pp. 265-301. Academic Press, San Diego, 1987.
22. D. J. Grdina, B. Nagy, C. K. Hill, R. L. Wells and C. Peraino, The radioprotector WR1065 reduces radiation-induced mutations at the hypoxanthine-guanine phosphoribosyl transferase locus in V79 cells. Carcinogenesis 6, 929-931 (1985).
23. P. L. Olive and J. P. Banath, Phosphorylation of histone H2AX as a measure of radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 58, 331-335 (2004).
24. J. P. Banath, S. H. MacPhail and P. L. Olive, Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res. 64, 7144-7149 (2004).
25. H. Mahrhofer, S. Burger, U. Oppitz, M. Flentje and C. S. Djuzenova, Radiation induced DNA damage and damage repair in human tumor and fibroblast cell lines assessed by histone H2AX phosphorylation. Int. J. Radiat. Oncol. Biol. Phys. 64, 573-580 (2006).
26. R. Mirzayans, D. Severin and D. Murray, Relationship between DNA double-strand break rejoining and cell survival after exposure to ionizing radiation in human fibroblast strains with differing ATM/p53 status: Implications for evaluation of clinical radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 66, 1498-1505 (2006).
27. G. D. Smoluk, R. C. Fahey, P. M. Calabro-Jones, J. A. Aguilera and J. F. Ward, Radioprotection of cells in culture by WR2721 and derivatives: Form of the drug responsible for protection. Cancer Res. 48, 3641-3647 (1988).
28. H. H. Evans, M. F. Horng, M. Ricanati and E. C. McCoy, Differential antimutagenicity of WR-1065 added after irradiation in L5178Y cell lines. Radiat. Res. 151, 391-397 (1999).
29. A. Molteni, J. E. Moulder, E. F. Cohen, W. F. Ward, B. L. Fish, J. M. Taylor, L. F. Wolfe, L. Brizio-Molteni and P. Veno, Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. Int. J. Radiat. Biol. 76, 523-532 (2000).
30. A. Molteni, J. E. Moulder, E. P. Cohen, B. L. Fish, J. M. Taylor, P. A. Veno, L. F. Wolfe and W. F. Ward, Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker. Exp. Biol. Med. 226, 1016-1023 (2001).
31. K. Hoekman, W. J. F. van der Vijgh and J. B. Vermorken, Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer. Drugs 57, 133-155 (1999).
32. M. Links and C. Lewis, Chemoprotectants: A review of their clinical pharmacology and therapeutic efficacy. Drugs 57, 293-308 (1999).
33. C. K. Sen, Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem. Pharmacol. 55, 1747-1758 (1998).
34. R. Neal, R. H. Matthews, P. Lutz and N. Ercal, Antioxidant role of N-acetyl cysteine isomers following high dose irradiation. Free Radic. Biol. Med. 34, 689-695 (2003).
35. A. M. Samuni, W. DeGraff, J. A. Cook, M. C. Krishna, A. Russo and J. B. Mitchell, The effects of antioxidants on radiation-induced apoptosis pathways in TK6 cells. Free Radic. Biol. Med. 37, 1648-1655 (2004).
36. S. Zheng, G. L. Newton, G. Gonick, R. C. Fahey and J. F. Ward, Radioprotection of DNA by thiols: Relationship between the net charge on a thiol and its ability to protect DNA. Radiat. Res. 114, 11-27 (1988).
37. S. Zheng, G. L. Newton, J. F. Ward and R. C. Fahey, Aerobic radioprotection of pBR322 by thiols: Effect of thiol net charge upon scavenging of hydroxyl radicals and repair of DNA radicals. Radiat. Res. 130, 183-193 (1992).
38. E. W. Ades, F. J. Candal, R. A. Swerlick, V. G. George, S. Summers, D. C. Bosse and T. J. Lawley, HMEC-1: Establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 99, 683-690 (1992).
39. Y. Kataoka, J. S. Murley, R. Patel and D. J. Grdina, Cytoprotection by WR-1065, the active form of amifostine, is independent of p53 status in human malignant glioma cell lines. Int. J. Radiat. Biol. 76, 633-639 (2000).
40. G. R. Guy, J. Cairns, S. B. Ng and Y. H. Tan, Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J. Biol. Chem. 268, 2141-2148 (1993).
41. J. S. Murley, A. Constantinou, N. S. Kamath and D. J. Grdina, WR-1065, an active metabolite of the cytoprotector amifostine, affects phosphorylation of topoisomerase IIα leading to changes in enzyme activity and cell cycle progression in CHO AA8 cells. Cell Prolif. 30, 283-294 (1997).
42. J. A. Ruiz-Gines, C. Perez-Caballero, F. O'Valle, M. Rodriguez-Puyol and D. Rodriguez-Puyol, Captopril inhibits pp60[c-src] tyrosine phosphorylation in cultured human mesangial cells. Eur. J. Pharmacol. 336, 251-256 (1997).
43. W. Y. Hu, Y. J. Han, L. Z. Gu, M. Piano and P. de Lanerolle, Involvement of ras-regulated myosin light chain phosphorylation in the captopril effects in spontaneously hypertensive rats. Am. J. Hypertension 20, 53-61 (2007).
44. R. D. Issels, T. H. Meier, E. Muller, G. Multhoff and W. Wilmanns, Ifosamide induced stress response in human lymphocytes. Mol. Aspects Med. 14, 281-286 (1993).
45. A. Mehta, C. P. S. Sekhon, S. Giri, J. K. Orak and A. K. Singh, Attenuation of ischemia/reperfusion induced MAP kinases by N-acetyl cysteine, sodium nitroprusside and phosphoramidon. Mol. Cell. Biochem. 240, 19-29 (2002).
46. 2 on the receptor tyrosine kinases, the MAP kinase cascade, and IκB kinases. Ann. NY Acad. Sci. 973, 419-422 (2002).